Background: Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) has been increasingly reported worldwide, posing a severe challenge to public health; however, the mechanisms driving its emergence and global dissemination remain unclear.
Methods: We analysed CR-hvKp strains derived from canonical hvKp backgrounds, and acquired a carbapenemase-encoding gene. These strains were identified from 485 CRKp isolates in the CRACKLE-2 China cohort, 259 CRKp isolates from a multi-centre study, and 67,631 K. pneumoniae genomes available in GenBank. Clinical isolates harbouring the IncFII KPC-2 plasmid were selected for genome sequencing, RNA-Seq, conjugation assays, in vivo, ex vivo, and in vitro phenotypic characterisation.
Findings: Analysis of clinical CR-hvKp isolates and the 414 genomes from 24 countries available in GenBank identified an IncFII KPC-2 plasmid as the prevalent KPC plasmid (detected in 25%, 45/178 of KPC-producing CR-hvKp). Compared with the epidemic IncFII KPC-2 plasmid, the IncFII KPC-2 plasmid exhibited a 100- to 1000-fold increase in conjugation frequency (10-10 vs. 10) and an in vitro growth advantage under meropenem challenge-likely due to the overexpression of conjugation-related genes and an increased bla copy number and expression. CR-hvKp isolates and hvKp transconjugants carrying this plasmid often exhibited reduced mucoviscosity, while retaining hypervirulence in both murine models and human neutrophil assays.
Interpretation: The IncFII plasmid may be a key factor driving the global dissemination of CR-hvKp, underscoring the urgent need for enhanced molecular surveillance of this emerging pathogen.
Funding: National Natural Science Foundation of China and National Institutes of Health.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ebiom.2025.105627 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Global emergence of Carbapenem-resistant Hypervirulent Klebsiella pneumoniae driven by an IncFII KPC-2 plasmid.
EBioMedicine
March 2025
Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, National Heath Commission of the People's Republic of China, Shanghai, China. Electronic address:
Background: Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) has been increasingly reported worldwide, posing a severe challenge to public health; however, the mechanisms driving its emergence and global dissemination remain unclear.
Methods: We analysed CR-hvKp strains derived from canonical hvKp backgrounds, and acquired a carbapenemase-encoding gene. These strains were identified from 485 CRKp isolates in the CRACKLE-2 China cohort, 259 CRKp isolates from a multi-centre study, and 67,631 K.
IS26-mediated cointegration generates a plasmid co-harbouring bla and bla in Klebsiella pneumoniae.
J Glob Antimicrob Resist
February 2025
Department of Laboratory Medicine, Hangzhou First People's Hospital, Hangzhou, China. Electronic address:
Background: This study aims to explore the phenotypic and genotypic characteristics of a plasmid that co-harbours bla and bla in a carbapenem-resistant Klebsiella pneumoniae.
Methods: Strain K194 was isolated from a 60-year-old patient. Species identification was performed with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, followed by antibiotic susceptibility testing.
Double carbapenemases in blood isolates: dissemination in a single medical center via multiple plasmids and a variety of highly efficient clones.
Antimicrob Agents Chemother
March 2025
First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Acquisition of multiple carbapenemase genes by (Kp) is an emerging public health threat. Here, we aim to elucidate the population structure of Kp blood isolates carrying two different carbapenemase genes and identify the mechanism facilitating their dissemination. The study was conducted in a tertiary healthcare center between 2014 and 2022.
View Article and Find Full Text PDFCharacterization of a novel KPC-2 variant, KPC-228, conferring resistance to ceftazidime-avibactam in an ST11-KL64 hypervirulent Klebsiella pneumoniae.
Int J Antimicrob Agents
March 2025
Department of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. Electronic address:
Article Synopsis
- The study investigates the mechanisms of resistance to ceftazidime-avibactam (CZA) in a hypervirulent strain of Klebsiella pneumoniae known as CRE146, which carries the bla gene.
- Researchers isolated twelve carbapenem-resistant Klebsiella pneumoniae strains from a single patient, employing whole genome sequencing and various pathogenicity tests to understand the virulence factors and resistance development.
- Findings revealed that the resistance was linked to drug exposure and involved specific genetic mutations in carbapenemase (KPC-228), with CRE146 showing high resistance to CZA while being more susceptible to other antibiotics like meropenem and imipenem.
First documentation of a clinical multidrug-resistant Enterobacter chuandaensis ST2493 isolate co-harboring bla and two bla bearing plasmids.
Sci Rep
November 2024
Department of Laboratory Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Article Synopsis
- The study highlights the rise of carbapenem-resistant Enterobacter chuandaensis, a rare member of the Enterobacter cloacae complex, complicating infection treatment.
- Researchers identified a specific strain, FAHZZU5885, from a patient in ICU, which carried multiple resistance genes and exhibited resistance to most antibiotics except a few.
- Genetic analysis revealed that the strain harbored two different plasmids containing carbapenemase genes, raising concerns about its potential to spread and contribute to further resistance issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!